223 related articles for article (PubMed ID: 28859028)
1. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
[TBL] [Abstract][Full Text] [Related]
2. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
3. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Kernan NA; Richardson PG; Smith AR; Triplett BM; Antin JH; Lehmann L; Messinger Y; Liang W; Hume R; Tappe W; Soiffer RJ; Grupp SA
Pediatr Blood Cancer; 2018 Oct; 65(10):e27269. PubMed ID: 29873895
[TBL] [Abstract][Full Text] [Related]
4. Two Cases of Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Thioguanine Treatment for Acute Lymphoblastic Leukemia.
Gruhn B; Brodt G; Mentzel HJ; Ernst J
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e572-e575. PubMed ID: 33885036
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.
Roy Moulik N; Johnson I; Van Bruggen L; Petterson T; Mycroft J; Vaidya SJ
Pediatr Blood Cancer; 2020 Nov; 67(11):e28677. PubMed ID: 32865880
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy: A Case Report and Review of the Literature.
Lawrence MR; Bassal M; Ramphal R; Johnston DL
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e788-e791. PubMed ID: 33902061
[TBL] [Abstract][Full Text] [Related]
7. Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.
Coutsouvelis J; Avery S; Dooley M; Kirkpatrick C; Spencer A
Cancer Treat Rev; 2016 Nov; 50():200-204. PubMed ID: 27721142
[TBL] [Abstract][Full Text] [Related]
8. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
10. The Role of Thromboelastography in Pediatric Patients with Sinusoidal Obstructive Syndrome Receiving Defibrotide.
Gendreau JL; Knoll C; Adams RH; Su LL
Biol Blood Marrow Transplant; 2017 Apr; 23(4):707-712. PubMed ID: 28115278
[TBL] [Abstract][Full Text] [Related]
11. Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.
Cecinati V; Giordano P; De Leonardis F; Grassi M; Arcamone G; De Mattia D; Santoro N
Immunopharmacol Immunotoxicol; 2009; 31(4):702-5. PubMed ID: 19874245
[TBL] [Abstract][Full Text] [Related]
12. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
13. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
14. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
[TBL] [Abstract][Full Text] [Related]
15. Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
Choi A; Kang YK; Lim S; Kim DH; Lim JS; Lee JA
Cancer Res Treat; 2016 Oct; 48(4):1443-1447. PubMed ID: 27034141
[TBL] [Abstract][Full Text] [Related]
16. Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.
Kotecha RS; Buckland A; Phillips MB; Cole CH; Gottardo NG
J Pediatr Hematol Oncol; 2014 Jan; 36(1):76-80. PubMed ID: 24276042
[TBL] [Abstract][Full Text] [Related]
17. Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience.
Sucak GT; Aki ZS; Yagcí M; Yegin ZA; Ozkurt ZN; Haznedar R
Transplant Proc; 2007 Jun; 39(5):1558-63. PubMed ID: 17580188
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Yakushijin K; Matsui T; Okamura A; Yamamoto K; Ito M; Chihara K
Kobe J Med Sci; 2005; 51(3-4):55-65. PubMed ID: 16444097
[TBL] [Abstract][Full Text] [Related]
19. Education and imaging. Hepatobiliary and pancreatic: sinusoidal obstruction syndrome during chemotherapy.
Menke J
J Gastroenterol Hepatol; 2011 Jun; 26(6):1083. PubMed ID: 21564291
[No Abstract] [Full Text] [Related]
20. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]